All changes for the tissue urinary system (132)

Identifier Name Type Tissues Organism Gene Data Actions
DAA880 Kidney mass gradually lost Physiological kidney Human — —
DAA265 complement component 1, s subcomponent Molecular kidney Human C1S 24.0% Increase Gene Expression Level
DAA289 brain protein 44-like Molecular kidney Human BRP44L 9.0% Decrease Gene Expression Level
DAA287 creatine kinase, brain Molecular kidney Human CKB 10.0% Decrease Gene Expression Level
DAA285 immunoglobulin kappa variable 1-5 Molecular kidney Human IGKV1-5 35.0% Increase Gene Expression Level
DAA277 tyrosinase-related protein 1 Molecular kidney Human TYRP1 21.0% Decrease Gene Expression Level
DAA274 immunoglobulin lambda variable 3-25 Molecular kidney Human IGLV3-25 46.0% Increase Gene Expression Level
DAA284 immunoglobulin lambda variable 4-3 Molecular kidney Human IGLV4-3 41.0% Increase Gene Expression Level
DAA261 hypothetical LOC100126583 Molecular kidney Human — 43.0% Increase Gene Expression Level
DAA260 hypothetical protein LOC284214 Molecular kidney Human — 53.0% Increase Gene Expression Level
DAA291 chromosome 1 open reading frame 162 Molecular kidney Human C1orf162 37.0% Increase Gene Expression Level
DAA259 immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides Molecular kidney Human IGJ 60.0% Increase Gene Expression Level
DAA894 Interstitial fibrosis in medulla Physiological kidney Human — —
DAA257 kininogen 1 Molecular kidney Human KNG1 17.0% Decrease Gene Expression Level
DAA283 lactotransferrin Molecular kidney Human LTF 115.0% Increase Gene Expression Level
DAA270 lipoprotein lipase Molecular kidney Human LPL 17.0% Decrease Gene Expression Level
DAA290 lysozyme (renal amyloidosis) Molecular kidney Human LYZ 57.0% Increase Gene Expression Level
DAA266 matrix metallopeptidase 7 (matrilysin, uterine) Molecular kidney Human MMP7 23.0% Increase Gene Expression Level
DAA2026 Mutations in mitochondrial DNA accumulate Physiological heart, kidney, skeletal muscle, cerebral cortex, cerebellum Human — —
DAA626 Essential (primary) hypertension and hypertensive renal disease Pathological heart, kidney Human — SeriesMorbidity
DAA279 nicotinamide N-methyltransferase Molecular kidney Human NNMT 40.0% Increase Gene Expression Level
DAA264 paraoxonase 3 Molecular kidney Human PON3 13.0% Decrease Gene Expression Level
DAA280 FXYD domain containing ion transport regulator 2 Molecular kidney Human FXYD2 5.0% Decrease Gene Expression Level
DAA278 Ras-related GTP binding D Molecular kidney Human RRAGD 14.0% Decrease Gene Expression Level
DAA1498 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 Molecular kidney Mouse Hmgcs1 4.0% Decrease Gene Expression Level